Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()

Detalles Bibliográficos
Autores principales: Raffi, Jodie, Suresh, Raagini, Berger, Timothy, Fishman, Harvey, Murase, Jenny E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938892/
https://www.ncbi.nlm.nih.gov/pubmed/31909162
http://dx.doi.org/10.1016/j.ijwd.2019.08.007
_version_ 1783484123565785088
author Raffi, Jodie
Suresh, Raagini
Berger, Timothy
Fishman, Harvey
Murase, Jenny E.
author_facet Raffi, Jodie
Suresh, Raagini
Berger, Timothy
Fishman, Harvey
Murase, Jenny E.
author_sort Raffi, Jodie
collection PubMed
description
format Online
Article
Text
id pubmed-6938892
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69388922020-01-06 Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()() Raffi, Jodie Suresh, Raagini Berger, Timothy Fishman, Harvey Murase, Jenny E. Int J Womens Dermatol Article Elsevier 2019-08-24 /pmc/articles/PMC6938892/ /pubmed/31909162 http://dx.doi.org/10.1016/j.ijwd.2019.08.007 Text en © 2019 Published by Elsevier Inc. on behalf of Women's Dermatologic Society. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Raffi, Jodie
Suresh, Raagini
Berger, Timothy
Fishman, Harvey
Murase, Jenny E.
Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
title Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
title_full Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
title_fullStr Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
title_full_unstemmed Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
title_short Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
title_sort nonsteroid management of residual ocular surface disease on dupilumab (rosdd),()()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938892/
https://www.ncbi.nlm.nih.gov/pubmed/31909162
http://dx.doi.org/10.1016/j.ijwd.2019.08.007
work_keys_str_mv AT raffijodie nonsteroidmanagementofresidualocularsurfacediseaseondupilumabrosdd
AT sureshraagini nonsteroidmanagementofresidualocularsurfacediseaseondupilumabrosdd
AT bergertimothy nonsteroidmanagementofresidualocularsurfacediseaseondupilumabrosdd
AT fishmanharvey nonsteroidmanagementofresidualocularsurfacediseaseondupilumabrosdd
AT murasejennye nonsteroidmanagementofresidualocularsurfacediseaseondupilumabrosdd

Ejemplares similares